Skip to content

IMMP

Immutep Limited

NASDAQ · Healthcare · Biotechnology · AU

$0.36
−0.05%
Ask drillr

Income statement

MetricTTM2026202520242023
Revenue
Total Revenue21.7M14.2M5.0M3.8M3.5M
Cost of Revenue109.1M2.4M61.4M41.5M2.1M
Gross Profit(87.4M)11.8M(56.4M)(37.7M)1.4M
Operating Expenses
R&D Expense61.4M75.0M61.4M41.5M28.8M
SG&A Expense63.2M18.9M8.6M8.9M14.1M
General & Admin Expense14.1M8.6M8.9M8.7M
Selling & Marketing Expense5.4M
Other Expenses2.1M
Total Operating Expenses124.6M93.9M70.1M50.4M44.9M
Cost and Expenses233.7M96.3M131.5M91.9M81.2M
Operating Income (EBIT)(212.0M)(82.0M)(126.4M)(88.1M)(77.7M)
Non-Operating
Interest Income8.2M2.9M5.3M3.9M939.0K
Interest Expense68.2K66.4K30.6K20.4K
Net Interest Income8.2M2.9M5.3M3.9M918.6K
Other Non-Op Income/Expense70.8M4.5M65.0M45.4M37.8M
Non-Operating Income (excl Interest)(61.4M)(61.4M)(41.5M)(36.3M)
EBT (Pre-Tax Income)(141.2M)(77.6M)(61.4M)(42.7M)(39.9M)
Income Tax Expense
Bottom Line
Net Income(141.2M)(77.6M)(61.4M)(42.7M)(39.9M)
Earnings from Cont. Ops(141.2M)(77.6M)(61.4M)(42.7M)(39.9M)
Earnings from Discont. Ops
Bottom Line Net Income(141.2M)(77.6M)(61.4M)(42.7M)(39.9M)
Per Share
Basic EPS($0.95)($0.53)($0.42)($0.36)($0.44)
Diluted EPS($0.95)($0.53)($0.42)($0.36)($0.44)
Revenue Per Share$0.15$0.10$0.03$0.03$0.04
Shares
Basic Shares Outstanding147.4M147.2M145.6M120.0M90.1M
Diluted Shares Outstanding147.4M147.2M145.6M120.1M90.1M
Profitability Metrics
EBITDA(146.2M)(79.6M)(62.9M)(44.5M)(39.6M)
D&A4.3M2.4M2.1M2.0M1.9M
EBIT(150.6M)(82.0M)(65.0M)(46.6M)(41.4M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026